Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort

by Koegl, C, Wolf, E, Hanhoff, N, Jessen, H, Schewe, K, Rausch, M, Goelz, J, Goetzenich, A, Knechten, H, Jaeger, H
Published 2009

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

by Stephan, C, Jaeger, H, Carganico, A, Knecht, G, Lutz, T, Mayr, C, Mosthaf, FA, Koeppe, S, Mueller, M, Wolf, E, Tappe, A, Wellmann, E, Knechten, H
Published 2010

The patient cohort of the German competence network for HIV/AIDS (KompNet):a profile

by Jansen, K, Michalik, C, Hahn, M, Dupke, S, Esser, S, Jaeger, H, Köppe, S, Moll, A, Plettenberg, A, Schmidt, RE, Skaletz-Rorowski, A, Brockmeyer, NH
Published 2009

The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infe...

by Knechten, H, Stephan, C, Mosthaf, FA, Jaeger, H, Carganico, A, Lutz, T, Schewe, K, Mayr, C, Wolf, E, Wellmann, E, Tappe, A
Published 2011

Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients

by Jansen, K, Sönnerborg, A, Pugliese, P, Biguenet, S, Eychenne, JL, Brockmeyer, NH, Michalik, C, Dupke, S, Jaeger, H, Plettenberg, A, Butcher, D, Jiménez-Expósito, MJ, KompNet, HIV
Published 2010

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany

by Wolf, E, Blankenburg, M, Bogner, JR, Becker, W, Gorriahn, D, Mueller, MC, Jaeger, H, Welte, R, Baudewig, M, Walli, R, Stoll, M
Published 2010